| Primary |
| Glaucoma |
58.1% |
| Intraocular Pressure Increased |
9.2% |
| Hypertension |
8.3% |
| Open Angle Glaucoma |
5.8% |
| Product Used For Unknown Indication |
2.8% |
| Diabetes Mellitus |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Intraocular Pressure Test Abnormal |
1.4% |
| Ocular Hypertension |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Hypothyroidism |
1.1% |
| Spinal Pain |
1.1% |
| Bone Disorder |
1.0% |
| Abdominal Pain Upper |
0.9% |
| Prostatic Disorder |
0.9% |
| Dry Eye |
0.8% |
| Cardiovascular Event Prophylaxis |
0.7% |
| Eye Disorder |
0.7% |
| Ulcerative Keratitis |
0.7% |
| Blood Pressure Abnormal |
0.6% |
|
| Intraocular Pressure Increased |
17.9% |
| Eye Irritation |
14.7% |
| Drug Ineffective |
13.6% |
| Ocular Hyperaemia |
7.5% |
| Eye Pain |
5.2% |
| Product Substitution Issue |
5.2% |
| Headache |
4.3% |
| Vision Blurred |
4.3% |
| Visual Impairment |
4.1% |
| Visual Acuity Reduced |
3.4% |
| Eye Pruritus |
3.2% |
| Eye Disorder |
2.9% |
| Product Quality Issue |
2.3% |
| Cataract |
1.8% |
| Death |
1.8% |
| Pruritus |
1.8% |
| Drug Effect Decreased |
1.6% |
| Vertigo |
1.6% |
| Erectile Dysfunction |
1.4% |
| Eye Swelling |
1.4% |
|
| Secondary |
| Glaucoma |
34.4% |
| Product Used For Unknown Indication |
21.6% |
| Intraocular Pressure Increased |
11.1% |
| Hypertension |
9.6% |
| Drug Use For Unknown Indication |
3.9% |
| Open Angle Glaucoma |
2.8% |
| Blood Cholesterol Increased |
2.3% |
| Intraocular Pressure Test |
1.7% |
| Thyroid Disorder |
1.6% |
| Diabetes Mellitus |
1.3% |
| Spinal Pain |
1.3% |
| Anterior Chamber Disorder |
1.2% |
| Eye Disorder |
1.1% |
| Macular Degeneration |
1.1% |
| Muscle Disorder |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Hypothyroidism |
0.9% |
| Ocular Hypertension |
0.9% |
| Muscle Spasms |
0.7% |
| Arthritis |
0.7% |
|
| Intraocular Pressure Increased |
18.9% |
| Drug Ineffective |
13.0% |
| Eye Irritation |
9.4% |
| Cataract |
6.7% |
| Vision Blurred |
4.7% |
| Visual Acuity Reduced |
4.7% |
| Headache |
4.3% |
| Eye Disorder |
3.9% |
| Ocular Hyperaemia |
3.9% |
| Vestibular Disorder |
3.9% |
| Vitreous Haemorrhage |
3.9% |
| Visual Impairment |
3.5% |
| Eye Pain |
3.1% |
| Intraocular Pressure Test Abnormal |
3.1% |
| Incorrect Dose Administered |
2.4% |
| Product Quality Issue |
2.4% |
| Drug Hypersensitivity |
2.0% |
| Product Substitution Issue |
2.0% |
| Rectal Haemorrhage |
2.0% |
| Visual Field Defect |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.7% |
| Drug Use For Unknown Indication |
15.4% |
| Glaucoma |
13.8% |
| Hypertension |
9.1% |
| Pain |
3.8% |
| Depression |
2.9% |
| Bacteraemia |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Atrial Fibrillation |
2.4% |
| Osteoporosis |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Prophylaxis |
1.9% |
| Non-small Cell Lung Cancer |
1.8% |
| Multiple Myeloma |
1.6% |
| Asthma |
1.5% |
| Blood Cholesterol Increased |
1.4% |
| Epilepsy |
1.3% |
| Diabetes Mellitus |
1.2% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Pneumonia |
1.1% |
|
| Visual Acuity Reduced |
11.0% |
| Myelodysplastic Syndrome |
7.0% |
| Toxic Epidermal Necrolysis |
6.5% |
| Weight Decreased |
6.5% |
| Renal Failure Acute |
6.3% |
| Death |
6.0% |
| Drug Ineffective |
5.2% |
| Hyponatraemia |
5.0% |
| Haemoglobin Decreased |
4.7% |
| Thrombocytopenia |
4.7% |
| White Blood Cell Count Decreased |
4.7% |
| Acute Generalised Exanthematous Pustulosis |
4.2% |
| Intraocular Pressure Increased |
3.9% |
| Palpitations |
3.9% |
| Atrial Fibrillation |
3.7% |
| Renal Impairment |
3.7% |
| Nausea |
3.4% |
| Vision Blurred |
3.4% |
| Vomiting |
3.4% |
| Hypotension |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
80.6% |
| Atrial Fibrillation |
9.7% |
| Osteoporosis |
6.5% |
| Glaucoma |
3.2% |
|
| Iridocyclitis |
33.3% |
| Diarrhoea |
16.7% |
| Intraocular Pressure Increased |
16.7% |
| Nasal Disorder |
16.7% |
| Visual Impairment |
16.7% |
|
